Related Experiment Video
Updated: Apr 24, 2026

Author Spotlight: Studying the Impact of Maternal Dietary Deficiencies on Long-Term Offspring Health Outcomes
Published on: June 28, 2024
Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia
Abstract:
Methylmalonic and propionic acidemia (MMA/PA) are inborn errors of metabolism characterized by accumulation of propionic acid and/or methylmalonic acid due to deficiency of methylmalonyl-CoA mutase (MUT) or propionyl-CoA carboxylase (PCC). MMA has an estimated incidence of ~ 1: 50,000 and PA of ~ 1:100'000 -150,000. Patients present either shortly after birth with acute deterioration, metabolic acidosis and hyperammonemia or later at any age with a more heterogeneous clinical picture, leading to early death or to severe neurological handicap in many survivors. Mental outcome tends to be worse in PA and late complications include chronic kidney disease almost exclusively in MMA and cardiomyopathy mainly in PA. Except for vitamin B12 responsive forms of MMA the outcome remains poor despite the existence of apparently effective therapy with a low protein diet and carnitine. This may be related to under recognition and delayed diagnosis due to nonspecific clinical presentation and insufficient awareness of health care professionals because of disease rarity.
Insights
Methylmalonic acidemia (MMA) and propionic acidemia (PA) are rare metabolic disorders. Early diagnosis and treatment are crucial for improving outcomes in these conditions.
Area of Science:
- Biochemistry
- Genetics
- Pediatrics
Background:
- Methylmalonic acidemia (MMA) and propionic acidemia (PA) are inherited metabolic disorders.
- These conditions result from deficiencies in methylmalonyl-CoA mutase (MUT) or propionyl-CoA carboxylase (PCC), leading to toxic acid accumulation.
- MMA/PA affect approximately 1 in 50,000 and 1 in 100,000-150,000 births, respectively.
Purpose of the Study:
- To summarize the clinical presentation, diagnostic challenges, and outcomes of MMA/PA.
- To highlight the importance of early recognition and management for affected individuals.
Main Methods:
- Literature review and synthesis of existing data on MMA/PA.
- Analysis of clinical manifestations, diagnostic criteria, and therapeutic approaches.
Main Results:
- Patients present with diverse symptoms, ranging from acute neonatal crisis to chronic neurological deficits.
- Long-term complications include neurological damage, chronic kidney disease (MMA), and cardiomyopathy (PA).
- Outcomes remain poor, even with treatment, often due to delayed diagnosis and rarity.
Conclusions:
- Under-recognition and delayed diagnosis contribute to poor outcomes in MMA/PA.
- Increased awareness among healthcare professionals is vital for timely intervention.
- Further research into novel therapeutic strategies is warranted to improve patient prognosis.
Related Concept Videos
Inborn Errors of Metabolism
Diagnosing Acidosis and Alkalosis
First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
Next, the PCO2 and...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Loss of Carboxy Group as CO2: Decarboxylation of Malonic Acid Derivatives
Amino Acid Biosynthetic Pathways
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...

